Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-acetylcysteine in Cannabis Withdrawal
NCT01439828Phase 2Terminated
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Feb 2012
- Primary completion
- Feb 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of acetylcysteine in cannabis withdrawal, cannabis use disorder (CUD), sponsored by Assistance publique - Hôpitaux de Paris. Started Feb 2012; status: terminated.
02
Drugs
acetylcysteine
03
Conditions
cannabis withdrawalcannabis use disorder (CUD)
Beyond the preview
Go deeper on NCT01439828.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01439828.